Cervical Cancer Awareness Month: Highlighting cervical cancer research at BMC - On Medicine

Cervical Cancer Awareness Month: Highlighting cervical cancer research at BMC - On Medicine

Aoife Buckley

Journal Development Editor at Springer Nature | BMC

Aoife Buckley is a Journal Development Editor at BMC and works on a wide range of titles across our oncology portfolio.

Cervical Cancer Awareness Month: Highlighting cervical cancer research at BMC

For Cervical Cancer Awareness Month, Editors across a number of BMC oncology journals have curated a compilation of articles highlighting the latest research in cervical cancer.

Aoife Buckley 7 Jan 2019

HPV vaccination. Credit: Benjamin Stratton, US Air Force.

January marks Cervical Cancer Awareness Month and, in recognition of this, we are proud to present a range of some of the latest cervical cancer research published across BMC’s oncology journals.

Despite being highly preventable through early screening methods and vaccination, cervical cancer remains the fourth most common cause of cancer among women worldwide.

Research into cervical cancer prevention, diagnostics, signaling pathways, and therapeutics is therefore crucial. The articles in this compilation have been curated by our cancer journal Editors and include the latest cervical cancer research from BMC in each of these four critical topics.

Cervical cancer prevention

Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia

Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures – a randomized controlled trial

Reducing incidence of cervical cancer: knowledge and attitudes of caregivers in Nigerian city to human papilloma virus vaccination

Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis

Risk assessment and diagnostics

Combined clinical and genetic testing algorithm for cervical cancer diagnosis

Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study

Signaling pathways

Association of HLA-G 3′ UTR polymorphism and expression with the progression of cervical lesions in human papillomavirus 18 infections

Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer

GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2

Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma

LncRNA PVT1 promotes the growth of HPV positive and negative cervical squamous cell carcinoma by inhibiting TGF-β1

Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p

Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression

Therapeutics  

High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events

Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis

Programmed cell death-ligand (PDL-1) is expressed in a significant number of the uterine cervical carcinomas